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PreviewsPak GITs to Aurora-A
The protein kinase Aurora-A orchestrates key aspects
of cell division, but its regulation has remained a ma-
jor puzzle. That puzzle is now one step closer to being
solved thanks to a recent paper by Zhao et al. appear-
ing in the October 28th issue of Molecular Cell. In this
work, the authors show that p21-activated kinases
(Paks), previously best known for their role in cyto-
skeletal and transcriptional signaling pathways, also
play an important role in centrosome dynamics via
phosphorylation and activation of Aurora-A.
The Aurora family comprises three serine/threonine ki-
nases (Aurora-A, -B, and -C), which are frequently over-
expressed in human cancers. Activation of Aurora-A is
required for mitotic entry and for successful cytokine-
sis, most likely due to its effects on centrosome dy-
namics and chromosome alignment (Marumoto et al.,
2005). As befits a kinase with such a central role on cell
division, the substrates of Aurora-A comprise a verita-
ble Who’s Who of cell cycle regulatory proteins, includ-
ing CDC25B, TACC, Ajuba, TPX2, BRCA1, CENP-A,
PP1, and p53 (Marumoto et al., 2005). Together, these
substrates are presumed to be responsible for at least
some of the many cell cycle activities ascribed to Au-
rora-A.
So far, so good, but how is Aurora itself activated?
Until this year, only two activators of Aurora-A were
known, the LIM-domain protein Ajuba (Goyal et al.,
1999) and the microtubule-associated protein TPX2
(Eyers et al., 2003). Ajuba, a member of the Zyxin family,
shuttles from sites of cell adhesion into the nucleus and
is thus a potential transducer of environmental signals.
Aurora-A interacts with Ajuba in mitotic cells, and Ajuba
is essential for activation of Aurora-A and for entry into
mitosis (Hirota et al., 2003). The second Aurora-A acti-
vator, TPX2, is required for mitotic spindle assembly
(Marumoto et al., 2005). More recently, the focal adhe-
sion scaffolding protein HEF1 (a member of the p130Cas
family) has been found to interact with and activate Au-
rora-A (Pugacheva and Golemis, 2005). All three of
these activators are also substrates of Aurora-A, and,
at least in the case of TPX2, it is thought that binding
induces allosteric effects that allow Aurora-A to lock
into an activated state by shielding a key phos-
phothreonine residue (Thr 288) from phosphatase at-
tack (Bayliss et al., 2003). While there is no reason to
doubt that such allosteric mechanisms are important, it
would seem that something more is required to get the
system going, since Thr 288 needs first to be phos-
phorylated, either by auto- or transphosphorylation, for
Aurora-A to be active. Zhao and colleagues tell us what
that something might be: p21-activated protein ki-
nases (Paks).Paks are effectors of the small GTPases Cdc42 and
Rac and have wide ranging effects on cell shape, move-
ment, proliferation, and survival (Zhao and Manser, 2005).
In cells, group I Paks (Pak1, -2, and -3) associate with
the Cdc42/Rac-specific guanine-nucleotide exchange
factor PIX, which itself is a partner of the Arf-GAP GIT1,
a protein that also binds to the focal adhesion protein
Paxillin. This four-member signaling machine (Pak/PIX/
GIT1/Paxillin) has a well-established role in regulating
focal adhesion turnover (Zhao and Manser, 2005). In
their report in Molecular Cell, Zhao et al. (2005) show
that at least three members of this signaling machine—
Pak, PIX, and GIT—also have a second function, that of
regulating centrosome maturation via phosphorylation
and activation of Aurora-A.
It has been known for some time that activated Pak
affects centrosome number. In 2000, Rakesh Kumar’s
group showed that overexpression of activated Pak1 in
MCF7 cells led to the accumulation of centrosomes
and aberrant mitoses (Vadlamudi et al., 2000). Later,
Pak1 was shown to localize to centrosomes in mitotic
cells and to become phosphorylated by the mitotic ki-
nase Cdc2 (Zhao and Manser, 2005). However, how
Pak1 got to centrosomes and what it did once there
were unsolved mysteries.
Zhao et al. show that GIT1 and its partner PIX, in
addition to their known role in localizing Pak and PIX
to focal adhesions, are also present at the centrosome
throughout all phases of the cell cycle. As cells near M
phase, Pak is recruited to centrosomes, though how
this happens remains unexplained for now. Activation
of Pak1 occurs only upon binding to PIX/GIT1, and,
interestingly, this occurs in a GTPase binding-indepen-
dent manner, excluding a role for the usual Pak activa-
tors Cdc42 or Rac. Artificially targeting Pak1 to centro-
somes also results in its activation, and removal of
centrosomes by cellular surgery prevents activation,
conclusively proving that the centrosome is the site of
Pak activation in mitotic cells.
Given that Pak has effects on centrosome number
and is activated at this structure, the authors looked for
an interaction between Pak1 and other protein kinases
that regulate various aspects of centrosome structure
and function. These experiments led them to find that
Pak1 can bind to and phosphorylate Aurora-A during
the mitotic phase of the cell cycle. They show that Pak1
phosphorylates Aurora-A at two sites—Thr 288 and Ser
342—that are important for activation of Aurora-A (Fer-
rari et al., 2005). However, only active forms of Pak1
can bind Aurora-A, whereas inactive Pak1 binds the
PIX/GIT1 complex, suggesting that the centrosomal
PIX/GIT1 complex activates Pak1, which then dissoci-
ates from the complex before phosphorylating Aurora-A
(Figure 1). If this cycle is perturbed, for example by
knockdown of PIX or inhibition of group I Paks, the ac-
cumulation of Aurora-A to centrosomes is delayed, al-
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574Figure 1. Pak Dynamics during the Cell Cycle
A Pak/PIX/GIT complex is present at focal adhesions in nonmitotic cells, anchored by Paxillin (green crescents). (1) During mitosis, Pak is
recruited to a centrosomal GIT1/PIX complex, which it binds via a PIX binding element (thick black rectangle). (2) Upon binding GIT1/PIX,
Pak undergoes a conformational change and becomes activated. The p21 binding regulatory domain of Pak (black/gray region) is not involved
in this activation step. Activated Pak dissociates from the complex, and the kinase domain (red box) binds Aurora-A, which Pak activates by
phosphorylation of Thr 288 and Ser 342. (3) Pak is inactivated and exits the centrosomal environment.though cells still manage to find a way to divide. These
findings suggest that the G2/M functions of Aurora-A
are under the control of another set of regulatory pro-
teins, such as TPX2.
The work of Zhao et al. is important not only because
it provides new insights into the activation of Aurora-A
but also because it supports the idea that there is sig-
nificant crosstalk between focal adhesions and the mi-
totic apparatus. Indeed, the pool of proteins that form
complexes at focal adhesions form the same complexes
at the centrosomes, as evidenced by the behavior of
Pak1/PIX/GIT1 or the presence of HEF1 and Ajuba at
both focal adhesions and centrosomes. It is possible
that disassembly of focal adhesions releases such pro-
tein complexes and leads to the activation of Aurora-A,
thereby linking loss of adhesion to cell cycle pro-
gression, such as that seen in “rounded-up” mitotic
cells. As is often the case when one particular puzzle
is solved, the findings of Zhao et al. bring new ques-
tions into view: What impels Pak to transit to and from
centrosomes during the cell cycle? What is the relation-
ship between Pak, Ajuba, and HEF1? Is this all part of
some grand scheme linking integrin signals to centro-
some maturation? For those answers, stay tuned, as
signaling and cell-cycle laboratories converge on Au-
rora-A .
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